CVS Health Powers Into Medicare & Medicaid with Aggressive Aetna Expansion Strategy; What Lies Ahead?

CVS Health reported a strong start to the year, with first quarter revenue of approximately $95 billion, a 7% increase compared to the previous year. The company’s adjusted earnings per share (EPS) reached $2.25, supported by improved performance across all segments. CVS Health adjusted its full-year 2025 guidance upwards to an EPS range of $6 to $6.20, an increase from the initial forecast of $5.75 to $6. This upward guidance was informed by solid execution and positive results despite a challenging environment.